story of the week
Safety, Tolerability, and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
Lancet 2022 Nov 04;[EPub Ahead of Print], A Mebazaa, B Davison, O Chioncel, A Cohen-Solal, R Diaz, G Filippatos, M Metra, P Ponikowski, K Sliwa, AA Voors, C Edwards, M Novosadova, K Takagi, A Damasceno, H Saidu, E Gayat, PS Pang, J Celutkiene, G CotterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.